Hepatitis A virus surface antigen — Drug Target
All drugs that target Hepatitis A virus surface antigen — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Marketed (2)
- Havrix 720 Junior · Chiang Mai University · Inactivated viral vaccine · Immunology / Infectious Disease
Havrix 720 Junior is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus. - Vaqta Injectable Product · National Taiwan University Hospital · Inactivated viral vaccine · Immunology / Infectious Disease
Vaqta is an inactivated hepatitis A vaccine that stimulates the immune system to produce antibodies against hepatitis A virus.